News

Crinetics Pharmaceuticals Investor Conference Participation

Crinetics Pharmaceuticals Investor Conference Participation

Crinetics Pharmaceuticals to Participate in Investor Conferences

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company committed to discovering and commercializing innovative therapies for endocrine diseases and related tumors, has announced its participation in two important investor conferences. Management will take part in fireside chats at both the Morgan Stanley 22nd Annual Global Healthcare Conference and the Cantor Global Healthcare Conference, scheduled for September.

Morgan Stanley 22nd Annual Global Healthcare Conference

At the Morgan Stanley 22nd Annual Global Healthcare Conference, Crinetics Pharmaceuticals will host a fireside chat on Wednesday, September 4, at 5:35 p.m. Eastern Time. This session will offer insights into the company’s innovative strategies and recent advancements.

Webcast Information

You can access the live webcast HERE.

Cantor Global Healthcare Conference

Crinetics will also be featured at the Cantor Global Healthcare Conference. The fireside chat is set for Wednesday, September 18, at 8:35 a.m. Eastern Time, where the company will outline its strategic vision and upcoming milestones.

Webcast Information

The live webcast link for this session can be found HERE.

Accessing Webcasts

Both live and archived webcasts from these conferences will be accessible on the Events & Presentations page within the Investors section of Crinetics’ official website at www.crinetics.com/events.

Opportunities for Meetings

Investors who wish to schedule one-on-one meetings with management during the conferences are encouraged to contact their respective conference representatives. This will provide an opportunity for more detailed discussions about Crinetics’ current projects and future plans.

About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics for endocrine diseases and tumors. One of their key candidates is paltusotine, a first-in-class oral somatostatin receptor type 2 (SST2) agonist, currently in Phase 3 clinical trials for acromegaly and Phase 2 trials for carcinoid syndrome associated with neuroendocrine tumors.

Recent Developments

Additionally, Crinetics is progressing with atumelnant (CRN04894), another first-in-class oral ACTH antagonist, which is nearing the completion of Phase 2 clinical studies for conditions like congenital adrenal hyperplasia and Cushing’s disease. The company emphasizes that all drug candidates are small-molecule entities developed through extensive in-house research.

Addressing a Range of Conditions

Crinetics is also focused on tackling various endocrine conditions, such as hyperparathyroidism, polycystic kidney disease, Graves’ disease, diabetes, obesity, and cancer indications that target GPCRs. Their dedication to innovative therapies underscores their significance in the medical community.

Investor Contacts

If you have any questions regarding investments or would like to reach out to management, please contact:
Gayathri Diwakar
Head of Investor Relations
gdiwakar@crinetics.com
(858) 345-6340

Media Contacts

For media inquiries, please reach out to:
Natalie Badillo
Head of Corporate Communications
nbadillo@crinetics.com
(858) 345-6075

Frequently Asked Questions

What is the focus of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals specializes in developing therapeutics for endocrine diseases and related tumors.

What investor conferences is Crinetics participating in?

Crinetics will be taking part in the Morgan Stanley and Cantor Global Healthcare Conferences.

Who can schedule meetings with Crinetics management?

Investors can arrange meetings through their conference representatives.

What is paltusotine?

Paltusotine is an oral somatostatin receptor type 2 agonist currently in Phase 3 clinical development for acromegaly.

How can I access the webcasts from the conferences?

The webcasts will be available on the Events & Presentations page of the Crinetics website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 2

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 5

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 10

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Nature-Based Solutions: The Economic And Community Impact

Updated Category News Views 6

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 4

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 3

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 1

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 1

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 1

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading
Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Updated Category News Views 3

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Continue Reading

Top 5 Most Recently Viewed Articles

Nobel Sustainability Trust Hosts Successful 2025 Summit in Miami

Updated Category News Views 180

Nobel Sustainability Trust's 2025 Summit Overview The Nobel Sustainability Trust (NST) successfully hosted its recent Annual Summit in Miami, creating a vibrant platform for leaders, policymakers, and innovators to come together. Held at a prominent venue, this summit served as a gathering point for visionaries aiming to foster solutions for a sustainable future. Key...

Continue Reading
Exploring the Liposarcoma Treatment Pipeline and Innovations

Updated Category News Views 241

Overview of Liposarcoma Treatment Pipeline The demand for innovative therapies in the liposarcoma treatment market is escalating due to a global rise in cancer cases and the need for effective treatments. Companies across the globe are working diligently to tackle this challenge by investing in research and development. The landscape is enriched by a focus on...

Continue Reading
Lendbuzz Concludes Major $262 Million Securitization Deal

Updated Category News Views 106

Lendbuzz Achieves Significant Milestone with Securitization Lendbuzz, a prominent AI-driven financial technology firm, has successfully closed a remarkable $262 million securitization, designated as "LBZZ 2024-3." This pivotal transaction is collateralized by a pool of auto loans made to consumers, secured by new and used vehicles, light-duty trucks, and vans. This...

Continue Reading
OSE Immunotherapeutics' Lusvertikimab: Game-Changer in UC Therapy

Updated Category News Views 279

Positive Phase 2 Results for Lusvertikimab in Ulcerative Colitis OSE Immunotherapeutics is making waves in the field of gastroenterology with its latest advancements in the treatment of ulcerative colitis (UC). The company recently presented comprehensive findings from its CoTikiS Phase 2 clinical trial, which investigated the efficacy of its anti-IL-7R monoclonal...

Continue Reading
Victors Home Solutions: Leading the Roofing Industry in 2024

Updated Category News Views 297

Victors Home Solutions Earns 2024 Roofing Contractor of the Year Title Victors Home Solutions proudly accepts its recognition as the 2024 Residential Roofing Contractor of the Year. This esteemed award showcases the company's exceptional dedication to quality and community service within the roofing industry. Celebrated at an Esteemed Conference On December 5, Victors...

Continue Reading